Programs & Services
Specialties & Conditions
Research Areas
Related Clinical Trials
Education
Education
|
University of Colorado Denver, PhD |
|
University of California School of Medicine (San Francisco), MD |
|
Stanford University (Palo Alto, CA), BS |
Residency
|
University of California (San Francisco), Intern and Resident, Internal Medicine |
Fellowship
|
National Jewish Health, Postdoctoral Fellow |
|
University of Colorado Denver, Pulmonary and Critical Care Medicine |
Awards & Recognition
2008: Best COPD Poster, European Respiratory Society
2006: Best COPD Poster, European Respiratory Society
2004: Astra Zeneca Young Investigator Travel Award in COPD
2002: American Heart Association Beginning Grant-in-Aid
2002: American Lung Association Research Grant (declined)
2001: Young Investigator Award, Society of Critical Care Medicine
Board Certification
1999: Critical Care Medicine (Recertification 2009)
1998: Pulmonary Medicine (Recertification 2008)
1996: American Board of Internal Medicine (Recertification 2006)
Professional Memberships
2002: American Physiological Society
2000: Society for Critical Care Medicine
1998: Society for Free Radicals in Biology and Medicine
1996: American Thoracic Society
Publications
Bowler RP, Nicks M, Tran K, Tanner G, Chang L-Y, Young SK, Worthen GS. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. Am J Respir Cell Mol Biol 31(4):432-9, 2004.
Bowler RP, Duda B, Chan ED, Enghild JJ, Ware LB, Matthay MA and Duncan MW. Proteomic anaysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 286(6):L1095-104, 2004.
Bowler RP, Arcaroli J, Abraham E, Patel M, Chang L-Y, and Crapo JD. Evidence for extracellular superoxide dismutase as a mediator of hemorrhage-induced lung injury. Am J Physiol Lung Cell Mol Physiol 284(4):L680-7, 2003.
Bowler RP, Sheng H, Enghild JJ, Pearlstein RD, Warner DS, and Crapo JD. A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. Free Rad Biol Med 33(8):1141, 2002.
Bowler RP, Nicks M, Thogersen IB, Valnickova Z, Hojrup P, Franzusoff A, Enghild JJ, and Crapo JD. Furin proteolytically processes the heparin binding region of extracellular superoxide dismutase. J Biol Chem 277(19):16505-11, 2002.
Hospital Affiliations
- Colorado Acute Long Term Hospital
- Kindred Hospital
- Rose Medical Center
- University of Colorado Hospital
Academic Affiliations
Associate Professor, University of Colorado Denver
Teaching & Professional Positions
2008 - Present: Associate Professor, Dept of Medicine, National Jewish Health
2006 - Present: Associate Professor, Dept of Medicine, University of Colorado Denver
2006 - Present: Director, COPD Clinic
2001 - 2008: Assistant Professor, Dept of Medicine, National Jewish Health
2001 - 2006: Assistant Professor, Dept of Medicine, University of Colorado Denver
2000 - 2001: Instructor, Dept of Medicine, National Jewish Health
2000 - 2001: Clinical Instructor, Dept of Medicine, University of Colorado Denver
Conflicts of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice
and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management
plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians
or scientists. View this faculty member’s industry relationships and collaborations.
Patient Ratings
The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.
Responses are measured on a scale of 1 to 5, with 5 being the best score.
Learn more about our patient satisfaction survey.
Provider showed concern
4.4
Spoke using clear language
4.7
Provider explained things clearly
4.6
Amount of time spent with you
4.6
Provider included you in decisions
4.4
Confidence in your doctor
4.6
Likelihood of recommending this provider
4.6